Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

Ocaliva recently failed to secure the FDA’s traditional approval for primary biliary cholangitis due to safety concerns.

The term "nonalcoholic fatty liver disease" (NAFLD ... and the modulation of fat storage. GLP-1 receptor agonists (GLP-1RAs) mimic the action of endogenous GLP-1 and have been shown to provide ...

Dan G. Duda, DMD, Ph.D., of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at ...

Further work is required to identify the effects of AHCC on the TLR receptors TLR2 and TLR4 in each of the liver cell types.

A higher risk of liver transplant and death was observed in Ocaliva-treated patients vs those who received placebo.

Selective activation of the thyroid hormone beta receptor in liver tissue is believed to favorably ... beta agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD).